MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Drug-induced parkinsonism(DIP)"

  • 2018 International Congress

    Levosulpiride Induced Movement Disorder: 7 cases

    D. Radhakrishnan, V. Goyal (New Delhi, India)

    Objective: Through this article we want to highlight extrapyramidal side effects of levosulpiride and need of its awareness among treating physicians. Background: Levosulpiride is a…
  • 2018 International Congress

    A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss

    R. Barmore, C. Hess, N. McFarland, M. Okun (Gainesville, FL, USA)

    Objective: To describe a case of tardive dyskinesia and parkinsonism following use of phentermine and briefly review the literature on tardive syndromes following use of…
  • 2018 International Congress

    Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan

    W. Lin, CY. Wei, HJ. Chen (ChangHua, Taiwan)

    Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…
  • 2017 International Congress

    Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: The aim of this study is measure the risk of PD related to hypertension and certain use of anti hypertensive treatment.   Background: Cardiovascular risk…
  • 2017 International Congress

    Transcranial sonography in the prognosis of drug-induced parkinsonism

    Y.-S. Oh, D.-Y. Kwon (Seoul, Republic of Korea)

    Objective: We investigated the substantia nigra (SN) echogenicity in drug-induced parkinsonism (DIP), Parkinson's disease (PD), and healthy controls. A subgroup analysis of DIP by clinical…
  • 2017 International Congress

    Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)

    H.-I. MA, S. Jang, J.-s. Kim, S.J. Chung, J.S. Baik, Y.J. Kim (Anyang, Republic of Korea)

    Objective: To evaluate the prevalence and characteristics of of drug induced parkinsonism Background: Drug induced parkinsonism (DIP) is a clinically important disease because it can…
  • 2017 International Congress

    Drug-induced movement disorders: not a typical problem

    A. Vives-Rodriguez, A. Patel (New Haven, CT, USA)

    Objective: To characterize patients with neuroleptic drug-induced movement disorders (DIMD) referred to a single academic center Movement Disorders clinic, their causative medications and the indications…
  • 2017 International Congress

    Risk of Parkinson’s disease in zolpidem user: A systematic review and meta-analysis

    S. Hussain, A.K. Najmi, D. Anil (New Delhi, India)

    Objective: To explore the association between zolpidem use and risk of Parkinson's disorder. Background: Zolpidem is commonly prescribed for the treatment of sleep disorder. Epidemiological…
  • 2017 International Congress

    Reversible progressive supranuclear palsy-mimic induced by risperidone

    H.J. Kim, J.H. Lee (Seoul, Republic of Korea)

    Objective: To report a patient who presented with a progressive supranuclear palsy (PSP)-like syndrome while receiving risperidone that disappeared after drug withdrawal. Background: Drugs that…
  • 2017 International Congress

    Tacrolimus induced parkinsonism presenting as freezing of gait and speech

    V. Paramanandam, H. DS, P.C. N (Chennai, India)

    Objective: Tacrolimus a calcineurin inhibitor is the most widely used immunosuppressant in post transplant patients. Mild adverse effects like tremors and parasthesia and occasionally major…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley